$30,000 of MIMEDX lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"regulatory issues related to the delivery of wound management and skin substitutes for Medicare patients"
You can find more data on corporate lobbying on Quiver Quantitative.
MDXG Insider Trading Activity
MDXG insiders have traded $MDXG stock on the open market 8 times in the past 6 months. Of those trades, 1 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $MDXG stock by insiders over the last 6 months:
- JOSEPH H CAPPER (Chief Executive Officer) purchased 200,000 shares for an estimated $1,268,000
- WILLIAM FRANK IV HULSE (General Counsel and CAO) has made 0 purchases and 3 sales selling 136,042 shares for an estimated $1,066,041.
- RICCI S WHITLOW (Chief Operating Officer) sold 61,420 shares for an estimated $508,557
- KIMBERLY MAERSK-MOLLER (Chief Commercial Officer) has made 0 purchases and 3 sales selling 7,976 shares for an estimated $64,281.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MDXG Hedge Fund Activity
We have seen 94 institutional investors add shares of MDXG stock to their portfolio, and 90 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CANNELL CAPITAL LLC removed 1,506,585 shares (-41.4%) from their portfolio in Q1 2025, for an estimated $11,450,046
- MILLENNIUM MANAGEMENT LLC added 596,016 shares (+93.9%) to their portfolio in Q1 2025, for an estimated $4,529,721
- BLACKROCK, INC. added 582,644 shares (+6.1%) to their portfolio in Q1 2025, for an estimated $4,428,094
- MEROS INVESTMENT MANAGEMENT, LP added 425,531 shares (+107.7%) to their portfolio in Q1 2025, for an estimated $3,234,035
- PHOCAS FINANCIAL CORP. added 380,014 shares (+1193.8%) to their portfolio in Q1 2025, for an estimated $2,888,106
- D. E. SHAW & CO., INC. added 363,630 shares (+149.7%) to their portfolio in Q1 2025, for an estimated $2,763,588
- MARSHALL WACE, LLP removed 348,747 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $2,650,477
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
MDXG Analyst Ratings
Wall Street analysts have issued reports on $MDXG in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Overweight" rating on 07/15/2025
To track analyst ratings and price targets for MDXG, check out Quiver Quantitative's $MDXG forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
